The FDA has approved Mflusiva, a new mRNA flu vaccine for adults 50 and older that utilizes COVID-19 vaccine technology for faster strain targeting.

Real-world evidence confirms the effectiveness of the 2025-2026 formulations of mRNA-1283 and BNT162b2 against severe SARS-CoV-2 outcomes in older adults, including hospitalization and medically ...

There’s a bit of a chill in the air, pumpkin spice in your coffee and children back to school — which means the threat of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Coadministration of COVID-19 and influenza vaccines may ...

Lauren writes about healthcare AI data interoperability, the science behind public health recommendations, and pharmaceutical advances in the rare disease space. Recent Covid vaccination appears to ...

Updated COVID-19 vaccines were approved by the FDA.

Sore throat, cough, fatigue–with the onset of cold season, these symptoms are likely to become more common again. However, it’s not always just a regular respiratory infection. COVID-19 is also ...

Cases and hospital admissions are on the rise, the UKHSA reveals ...

There's a bit of a chill in the air, pumpkin spice in your coffee, and children back to school — which means the threat of ...

Ontario has started its vaccination rollout for COVID-19 and flu vaccines, with high-risk recipients up first, while some ...